Birdwatch Archive

Birdwatch Note

2023-01-26 20:45:15 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Late 2022 meta-analyses continue to show a significant reduction in transmission from Covid vaccination and boosting: "The overall vaccine efficacy to prevent SARS-CoV-2 infection obtained in this study was 89.1% (95% CI 85.6–92.6%) against the placebo." https://link.springer.com/article/10.1007/s43440-022-00429-1 https://www.science.org/doi/10.1126/science.abl4292 https://www.science.org/doi/10.1126/science.abm3087

Written by B289B7B9A72A2B21A5016714B5CFECC892B67D4EF528AD49D229201250F7B83A
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1618335420957478913

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1618711686906785794
  • noteId - 1618711686906785794
  • participantId - B289B7B9A72A2B21A5016714B5CFECC892B67D4EF528AD49D229201250F7B83A
  • noteAuthorParticipantId -
  • createdAtMillis - 1674765915023
  • tweetId - 1618335420957478913
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Late 2022 meta-analyses continue to show a significant reduction in transmission from Covid vaccination and boosting: "The overall vaccine efficacy to prevent SARS-CoV-2 infection obtained in this study was 89.1% (95% CI 85.6–92.6%) against the placebo." https://link.springer.com/article/10.1007/s43440-022-00429-1 https://www.science.org/doi/10.1126/science.abl4292 https://www.science.org/doi/10.1126/science.abm3087

Note Ratings

rated at rated by
2023-01-29 15:42:54 -0600 00F109810F25821BACB5F67AE04A068F02A7E8FBA7F889B82ADE94482EA2D298 Rating Details
2023-01-27 18:23:49 -0600 0E3F6EB4AAF7233033251BACE0F0325D12DBDA5E1D67354D15807134017D9D96 Rating Details
2023-01-27 10:06:40 -0600 10EE297600F76B446808F62AC3BBF015AAC4FF8EF1CF717BDFA3E3E838A6B2D2 Rating Details
2023-01-27 03:02:26 -0600 159E77F7A49939858F70E428C351744792986C7CF9F2B051870149351425B88E Rating Details
2023-01-29 17:34:22 -0600 1B3AABC40AD0516371578D6583EDFE631183D5EF6225A4E33B8D7B96A95C5373 Rating Details
2023-01-26 21:43:30 -0600 20D672D535AA74BAB9A0581CEFA76A0E77F3912FB4910C8229A436F3368798E3 Rating Details
2023-01-28 09:25:24 -0600 248AF2C00311C9F2DD11E002DB33E10A8DC3628D3FBD291637F8070AF4799E42 Rating Details
2023-01-26 14:56:30 -0600 2C0C323337CADA4A449209AD8ECF2954421020C33C0FDAF5CAA4DD9CD50A4B60 Rating Details
2023-01-26 20:36:41 -0600 2D859468E6ACF0CAAC1219D3C6C6FF4C44A8DA8F794B0E1E9D2711B8F2C62936 Rating Details
2023-01-27 01:00:36 -0600 345D3CB454BE0855B3E314A180C287F4A96969D2B0276CFD187B5463B1C1D059 Rating Details
2023-01-30 10:17:17 -0600 373B7DE50DC490C95349BF11A8506D7AE8CF893E3549D14DAF3F504E1DE61796 Rating Details
2023-01-27 18:16:34 -0600 3E6159020CC0DF5D00799DA1B18015AFBDA02FD51E440BBA230058FCD4E5ABF3 Rating Details
2023-01-27 20:27:38 -0600 3E8D29DE9256F70881C64DC6F34D36A7B28F270495E6824F8D35AF7F3CBD3479 Rating Details
2023-01-28 01:17:50 -0600 441F71D07F57C8A98779F335C19990BA9B79FACBF0FCDE35632536B8520EC84D Rating Details
2023-01-27 13:21:11 -0600 4A08A16EDFA31E6D7BD170AEC8253C9D43F3C0037AEE1AD46D0D9429C506C92C Rating Details
2023-01-27 10:49:36 -0600 51DB90ACC3426EFE683D22B0C05D6E9EAB509871F1A8C64347BD2E9AD44D0EEE Rating Details
2023-01-26 17:08:59 -0600 55DD8845CB36D4A3C8FF939830B75C3B46088E7B5C2E475F714CFB4866CD4249 Rating Details
2023-01-26 14:49:20 -0600 5B66C2C2840AD455FDAC3D1F25BF92AD35DB04D16E6BE11F99C2E62BAC83F418 Rating Details
2023-01-26 16:40:10 -0600 5EDC2B8BBEA2C25FBA40E8849AF6DD751A4AE52F674E4E2311C09F82909AD4F8 Rating Details
2023-01-26 19:06:06 -0600 66C73EAE8D6B70C3640AE922F11A80106402329A687072A868245FCAC478CCA9 Rating Details
2023-01-29 16:03:42 -0600 6B5FA9F4D0BCD660DD519C21C4F646EAA6A47D2DD10B2D5314921536B8EEDDB5 Rating Details
2023-01-27 06:49:47 -0600 703A1C75F878AEBB92CB883BE8F974481EAFF91DCCA5A9E35B7E8E2CCE6097AA Rating Details
2023-01-27 10:54:42 -0600 72A59FB5955991E68C6349DA62C35A734500BE2AEFDA828D7BB704AB0E76465C Rating Details
2023-01-26 19:48:59 -0600 78357D46F6554A11287C08A3273858EC308C337D88A8C2CE9B7A36601938BE5B Rating Details
2023-01-27 09:32:43 -0600 8397B8EFF5E66D74E3D766849AAD6651C15A83BE48BE57BF0E5A1A8D5A1A4AE7 Rating Details
2023-01-27 14:00:45 -0600 992932B0527A672C23AE61796C01072F45C13496756A150528BB74653898B6D4 Rating Details
2023-01-27 19:28:33 -0600 9B3A3A0365562199849394497F8F644780E997D27185A37636D44437D359D5C3 Rating Details
2023-01-26 18:24:29 -0600 A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 Rating Details
2023-01-27 06:51:09 -0600 B04FB014FD7A6927D8AB07FBFB95A39262F7E8C68AD5F481CF7A7343B63BB223 Rating Details
2023-01-27 07:13:09 -0600 B89AC6CB34377FC7EB3F65B1CD705118D84C1751DAAAF43971C1D721B24E1EA3 Rating Details
2023-01-26 16:43:45 -0600 B9A9382D9039D0A1D4EF6385C72450F92C6E52A1B4D5AF9A7C20E0465A939DFB Rating Details
2023-01-27 05:10:52 -0600 BC1FD92D4650BDAE74B03FCAB57D2DD3A0E369957816F5517D11A1A50AEC9838 Rating Details
2023-01-27 05:02:28 -0600 C533C381ACD20C34EA4A6AC0F8C71310EA0AAFFAF601399F3A934A9B5B9CF379 Rating Details
2023-01-26 16:36:44 -0600 C966E0BA5803EDA2B9ADEA1A226B5D5FB13629349A2D9A920F01C5137F8AF13B Rating Details
2023-01-27 07:10:50 -0600 CEA5A61A82152004C465BD808928539F724FEB99D770DD8FB8BD5513EDF56E24 Rating Details
2023-01-29 17:59:25 -0600 D4A9C40AB6BAE0DA4C3F4932DCEE20072C5B0F8B7ADED1EE5E1F89CCD90E6E37 Rating Details
2023-01-26 18:17:47 -0600 E2F56F92FCFE1099A1FF9A7E6E291D585F0800B13B4C8E7B290D2E06512C6E58 Rating Details
2023-01-27 09:26:46 -0600 F31EF85704A5DA7009FE991FC5953D12FB18A79D60A6202A6B8C669311E97254 Rating Details
2023-01-26 16:12:45 -0600 F5A4C749B2A3A25AAD274CFABDEB194EBABB1107B72737670ACBA2B1D9212B42 Rating Details
2023-01-27 04:13:47 -0600 Rating Details
2023-01-26 16:36:44 -0600 Rating Details
2023-01-29 16:03:42 -0600 Rating Details
2023-01-26 19:06:06 -0600 Rating Details
2023-01-27 01:00:36 -0600 Rating Details
2023-01-26 21:43:30 -0600 Rating Details
2023-01-27 19:28:33 -0600 Rating Details
2023-01-26 16:12:45 -0600 Rating Details
2023-01-26 18:24:29 -0600 Rating Details
2023-01-27 10:06:40 -0600 Rating Details
2023-01-27 05:10:52 -0600 Rating Details
2023-01-27 05:02:28 -0600 Rating Details
2023-01-27 09:32:43 -0600 Rating Details
2023-01-26 18:17:47 -0600 Rating Details
2023-01-27 18:16:34 -0600 Rating Details
2023-01-28 09:25:24 -0600 Rating Details
2023-01-27 14:00:45 -0600 Rating Details
2023-01-26 17:08:59 -0600 Rating Details
2023-01-26 19:48:59 -0600 Rating Details
2023-01-27 07:13:09 -0600 Rating Details
2023-01-26 14:49:20 -0600 Rating Details
2023-01-27 18:23:49 -0600 Rating Details
2023-01-27 10:54:42 -0600 Rating Details
2023-01-27 13:21:11 -0600 Rating Details
2023-01-27 06:51:09 -0600 Rating Details
2023-01-27 06:49:47 -0600 Rating Details
2023-01-27 04:13:47 -0600 Rating Details
2023-01-26 16:43:45 -0600 Rating Details
2023-01-27 03:02:26 -0600 Rating Details
2023-01-26 20:36:41 -0600 Rating Details
2023-01-26 14:56:30 -0600 Rating Details
2023-01-27 20:27:38 -0600 Rating Details
2023-01-29 17:34:22 -0600 Rating Details
2023-01-28 01:17:50 -0600 Rating Details
2023-01-27 09:26:46 -0600 Rating Details
2023-01-29 15:42:54 -0600 Rating Details
2023-01-26 16:40:10 -0600 Rating Details
2023-01-29 17:59:25 -0600 Rating Details
2023-01-30 10:17:17 -0600 Rating Details
2023-01-27 07:10:50 -0600 Rating Details
2023-01-27 10:49:36 -0600 Rating Details